Professional medical & aesthetic supply For eligible business and healthcare customers
Contact Sales ↗
Home/Our Products/Stivarga 40 mg, 84 tablets
Stivarga 40 mg, 84 tablets

Stivarga 40 mg, 84 tablets

Capacity: 84 film-coated tablets
Category: Specialty Care, Oncology
Availability: In stock
More product details ›
Quantity:
Request a Quote

Stivarga 40 mg, 84 tablets (Regorafenib 40 mg per tablet) by Bayer.

Indications: Metastatic colorectal cancer, GIST and hepatocellular carcinoma after prior therapy.

Administration: Oral: 160 mg (4 tablets) once daily for 3 weeks, then 1 week off, after a light low-fat meal.

Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.

Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.

ManufacturerBayer
Active ingredientRegorafenib 40 mg per tablet — multikinase inhibitor.
Strength & pack84 film-coated tablets (3 bottles × 28).
FormFilm-coated tablets
StorageStore below 25–30 °C in the original package. Keep out of the sight and reach of children.
Regulatory statusPrescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.